Published on
February 24, 2026
- 13:30 GMT
TremeBio Launches to Advance Lymphatic-Targeting Drug Delivery Platform
Foundational Technology Developed and Contracted from Georgia Institute of Technology ATLANTA, GA, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- TremeBio Inc., a newly formed biotech company, today announced its launch to advance ProLymphNano ( …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
